Navigation Links
FDA Grants Chimerix Fast Track Designation for CMX001 for the Prevention of Clinically Significant Cytomegalovirus Infection
Date:3/12/2013

RESEARCH TRIANGLE PARK, N.C., March 12, 2013 /PRNewswire/ -- Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for CMX001 for the prevention of cytomegalovirus (CMV) infection.  CMX001 is the company's broad spectrum, oral nucleotide analog lipid-conjugate that blocks replication of double-stranded DNA (dsDNA) viruses.

The Fast Track program of the FDA is designed to facilitate the development and expedite the review of new drugs that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs.  Fast Track-designated drugs ordinarily qualify for priority review, thereby expediting the FDA review process.

CMX001 has completed Phase 2 clinical development for the prevention of CMV infection in adult hematopoietic stem cell transplant (HSCT) recipients.  Chimerix is preparing to initiate SUPPRESS, its Phase 3 study of CMX001 for the prevention of CMV infection in adult HSCT recipients, in 2013.  The company has previously received Fast Track designation for its CMX001 development programs for preemptive treatment of adenoviral disease in patients post HSCT and for the treatment of smallpox.

About Chimerix and CMX001
Chimerix is committed to the discovery, development and commercialization of novel, oral antiviral therapeutics designed to transform patient care in areas of high unmet medical need.  The Company's proprietary lipid technology has given rise to two clinical-stage lipid acyclic nucleoside phosphonates, CMX001 and CMX157, which have demonstrated the potential for enhanced activity and safety in convenient, orally administered dosing regimens. 

Chimerix's lead product candidate, CMX001, is a broad spectrum, oral nucleotide analog lipi
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pancreatic Cancer Action Network Opposes Sequestration Cuts To National Institutes Of Health & Cancer Research Grants
2. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
3. Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center
4. FDA Grants Orphan Drug Status To Eisais Lenvatinib
5. FDA Grants 510(k) clearance for new Fluke Biomedical ESA615 Electrical Safety Analyzer
6. U.S. FDA Grants Priority Review to Bayers Radium Ra 223 Dichloride NDA for Castration-Resistant Prostate Cancer with Bone Metastases
7. Afraxis Grants Exclusive Global License to Genentech
8. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
9. New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
10. Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology
11. New Jersey Health Foundation Commits $2 Million to Fund Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Ill. , May 4, 2015 RadiologyAuction will ... with live video and product demonstrations at the end ... imaging equipment such as Kodak and Fuji Cr,s, Agfa ... auctioned at the first event. Various imaging equipment will ... www.RadiologyAuction.com . After years of buying and ...
(Date:5/4/2015)... , May 4, 2015 PharmaEngine, Inc. ... Pharmaceuticals, Inc. (NASDAQ: MACK ) with its ... ) jointly announced that Baxter has submitted a ... Agency (EMA) for MM-398 (irinotecan liposome injection), also ... of the pancreas who have been previously treated ...
(Date:5/4/2015)... Pa. , May 4, 2015  Makindus, Inc. ... today that the European Medicines Agency (EMA) has granted ... the treatment of Stargardt,s Disease. "We are ... MI-100 to treat Stargardt,s disease in place for ... development program in the United States ...
Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2
... , WALTHAM, Mass., Nov. 17 Decision Resources, one ... and healthcare issues, finds that sales of agents to treat ... decade, increasing from $360 million in 2008 to $450 million ... the United Kingdom and Japan. , The new Pharmacor report ...
... 16 Symmetry Medical Inc. (NYSE: SMA ), a ... and other medical markets, announced today that Brian S. Moore, President ... and Chief Financial Officer, are scheduled to present at the 21st ... New York City on Tuesday, December 1, 2009 at 12:30 p.m. ...
Cached Medicine Technology:Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing From $360 Million in 2008 to $450 Million in 2018 2Symmetry Medical to Present at 21st Annual Piper Jaffray Health Care Conference 2
(Date:5/4/2015)... (PRWEB) May 04, 2015 Malibu ... oral antiseptic breath spray. KissSafe™ is the first ... a safer experience while adding fresh breath appeal. ... and effectively kills germs in the mouth and ... also contains ingredients that possess additional wellness benefits. ...
(Date:5/4/2015)... Milton Hershey School® has named J. Anthony Graves, ... recognizing his commitment to pediatric cancer research and the ... students. , “Dr. Graves is a tremendous example of ... a top-notch education, a nurturing environment, and the opportunity ... ’85, president of MHS. “He is applying the values ...
(Date:5/4/2015)... Johnson & Wales University (JWU) held a groundbreaking ceremony ... on Wednesday, April 22. , Johnson & Wales becomes the ... the re-alignment of Interstate-195. JWU’s new academic building, which will ... in Providence, is scheduled to be completed in July 2016. ... university purchased in 2012. , “It has long been our ...
(Date:5/4/2015)... The opportunity for children to dream of a ... forces behind The Fairy Godmother Next Door, a new children’s ... Stark. , The inspiration for the enchanting story of a ... Stark’s desire to be a fairy godmother. , “My wish ... my neighbors’ children since they were born. We discuss fairies ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Now in ... IPC clinical leaders who have made outstanding contributions to ... they serve, both in acute and post-acute care settings. ... Year, Post-Acute Provider of the Year, Advanced Practice Clinician ... Specialist Provider of the Year. Recipients are selected by ...
Breaking Medicine News(10 mins):Health News:80 Million Germs from Kissing - Introducing KissSafe™ 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3
... NEW YORK, June 25 International superstar Beyonce will perform ... to benefit the Charles & Phyllis Newman Foundation and the ... the most widely recognized and highly respected women in pop ... album I Am . . . Sasha Fierce ...
... , , Company,s Behavioral Health Grants Now ... ValueOptions(R), Inc., of Norfolk, Virginia, the behavioral health organization ... Mexico since 2005, announced today that it is awarding $3.1 ... services across the state. , , (Logo: ...
... ... Institute (SSI) announces the launch of the National ObamaCare Opt Out (NOOO!) ... not force them to join a national healthcare system, nor to purchase ... http://www.patientoptout.com , is modeled after the National Do Not Call Registry, and ...
... ... Children with Muscular Dystrophy , ... Boston, MA (PRWEB) June 25, 2009 -- In immediate response to the Muscular Dystrophy Association,s ... virus, more commonly known as the "swine flu" Camp Promise, today announced its efforts to ...
... 25 According to Millennium Research Group (MRG), ... pharmacomechanical thrombectomy (PMT) procedure adoption will accelerate over ... interest in treating deep vein thrombosis (DVT). Although ... Adjunctive Catheter-Directed Thrombolysis) trial, which will compare catheter-directed ...
... Prompts Addition of Veteran Sales Executives to Premium Provider of ... June 25 MedPro Imaging, a premium provider of new ... sales executives in support of ongoing growth. MedPro, which recently ... quarter of 2009, has named Scott Wayman the zone manager ...
Cached Medicine News:Health News:ValueOptions(R) Reinvests $3.1 Million in New Mexico 2Health News:Social Security Institute Launches the National Obamacare Opt Out (NOOO!) Registry 2Health News:Social Security Institute Launches the National Obamacare Opt Out (NOOO!) Registry 3Health News:Camp Promise Rallies To Provide Massachusetts Children With Alternative To MDA Canceled Summer Camp 2Health News:Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group 2Health News:Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group 3Health News:MedPro Imaging Adds Wayman and Sanford to Growing Sales Team 2Health News:MedPro Imaging Adds Wayman and Sanford to Growing Sales Team 3
Half aprons used to protect pelvic regions...
Light and comfortable thyroid protection. The softest, most comfortable throid collar made. No neck irritating binding....
... full protection is necessary, the Two-Piece ... add to your comfort through more ... greater flexibility. The vest comes with ... hanging loops as well as an ...
... Apron has standard front protection. ... from the shoulders to the ... a 6" wide elastic belt. ... fit various sized individuals. Available ...
Medicine Products: